We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Case studies from across the health and social care sector showing examples of good practice in preventing health problems from happening.
Monthly results for the REACT-1 study of coronavirus transmission.
See our work in action through these real world examples.
This Young Lives impact case study details the influence of Young Lives on the design and methodology of other studies
An overview of national surveillance programmes that explain the transmission of COVID-19 and other priority infections and how they are affecting the wider population.
How to use a cost benefit analysis to evaluate your digital health product.
Data on the real-world efficacy of the COVID-19 vaccines.
International comparison studies of education including reports of England’s results in OECD PISA, and IEA TIMSS and PIRLS studies.
A collection of University case studies with an intellectual property focus.
Find out when to prepare a water cycle study for your proposed development plan document, or development, and what to focus on.
How to use usability testing to evaluate your digital health product.
Find out about the important analysis work carried out by Dstl and its impact on UK defence and security.
How to use a cost effectiveness analysis to evaluate your digital health product.
An overview of QCA's studies to address the issue of standards across A level subjects.
Following MHRA approval of a clinical trial, a study on Nuwiq, a recombinant FVIII therapy for the treatment of haemophilia A, can proceed.
Details of the department's research reports commissioned since 1 January 2023.
How to use focus groups to evaluate your digital health product.
A collection of case studies showing how businesses have used patents to protect their ideas and help them grow.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).